Showing results (561-570 of 584) with videos related to
Sort By:
Pageof 59
BMC Medicine|October 18, 2018
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB studyM E Murphy, G H Wills, S Murthy, et al.American Journal of Primatology|March 6, 2003
Demography, female life history, and reproductive profiles among the chimpanzees of MahaleToshisada Nishida, Nadia Corp, Miya Hamai, et al.Science Translational Medicine|May 30, 2014
Photoactivation of endogenous latent transforming growth factor-β1 directs dental stem cell differentiation for regenerationPraveen R Arany, Andrew Cho, Tristan D Hunt, et al.Lancet (London, England)|November 29, 2005
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialA Keech, R J Simes, P Barter, et al.The Lancet. Respiratory Medicine|January 17, 2014
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatmentSven O Friedrich, Andrea Rachow, Elmar Saathoff, et al.Journal of the American Veterinary Medical Association|February 20, 2014
Outbreak of Salmonella enterica serotype Infantis infection in humans linked to dry dog food in the United States and Canada, 2012Maho Imanishi, David S Rotstein, Renate Reimschuessel, et al.Pediatric Rheumatology Online Journal|April 25, 2023
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectivesLeigh A Stubbs, Andrew M Ferry, Danielle Guffey, et al.The Lancet. Respiratory Medicine|January 28, 2014
Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational studyJosephine M Bryant, Simon R Harris, Julian Parkhill, et al.Neurology|January 26, 2011
Muscle histology vs MRI in Duchenne muscular dystrophyM Kinali, V Arechavala-Gomeza, S Cirak, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trialC H Barcenas, S A Hurvitz, J A Di Palma, et al.Pageof 59